当前位置: X-MOL 学术Scand. J. Clin. Lab. Invest. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Reproducibility of the CO rebreathing technique with a lower CO dose and a shorter rebreathing duration at sea level and at 2320 m of altitude
Scandinavian Journal of Clinical and Laboratory Investigation ( IF 2.1 ) Pub Date : 2020-09-21
Laura Oberholzer, Thomas Christian Bonne, Andreas Breenfeldt Andersen, Jacob Bejder, Regitse Højgaard Christensen, Nikolai Baastrup Nordsborg, Carsten Lundby

Total hemoglobin mass (Hbmass) is routinely assessed in studies by the carbon monoxide (CO) rebreathing. Its clinical application is often hindered due to the consequent rise in carboxyhemoglobin (%HbCO) and the concern of CO toxicity. We tested the reproducibility of the CO rebreathing with a CO dose of 0.5 mL/kg body mass (CO0.5) compared to 1.5 mL/kg (CO1.5) and when shortening the CO rebreathing protocol. Therefore, CO rebreathing was performed 1×/day in eight healthy individuals on four consecutive days. On each day, either CO0.5 (CO0.5-1 and CO0.5-2) or CO1.5 (CO1.5-1 and CO1.5-2) was administered. Venous blood samples to determine %HbCO and quantify Hbmass were obtained prior to, and at 6 (T6), 8 (T8) and 10 min (T10) of CO rebreathing. This protocol was tested at sea level and at 2320 m to investigate the altitude-related measurement error. At sea level, the mean difference (95% limits of agreement) in Hbmass between CO0.5-1 and CO0.5-2 was 26 g (–26; 79 g) and between CO1.5-1 and CO1.5-2, it was 17 g (–18; 52 g). The respective typical error (TE) corresponded to 2.4% (CO0.5) and 1.5% (CO1.5), while it was 6.5% and 3.0% at 2320 m. With CO0.5, shortening the CO rebreathing resulted in a TE for Hbmass of 4.4% (T8 vs. T10) and 14.1% (T6 vs T10) and with CO1.5, TE was 1.6% and 5.8%. In conclusion, the CO dose and rebreathing time for the CO rebreathing procedure can be decreased at the cost of a measurement error ranging from 1.5-14.1%.



中文翻译:

在海平面和海拔高度为2020 m的情况下,CO呼吸技术的可重复性较低,CO剂量较低,呼吸时间较短

在研究中,通常通过一氧化碳(CO)呼吸来评估总血红蛋白质量(Hb mass)。由于羧基血红蛋白(%HbCO)的增加以及对CO毒性的关注,其临床应用常常受到阻碍。我们以0.5 mL / kg体重(CO 0.5)与1.5 mL / kg(CO 1.5)的CO剂量测试了CO再呼吸的重现性,并缩短了CO再呼吸方案。因此,连续四天在八名健康个体中每天进行1次CO呼吸。每天使用CO 0.5(CO 0.5 -1和CO 0.5 -2)或CO 1.5(CO 1.5 -1和CO 1.5-2)。在CO呼吸之前和6(T 6),8(T 8)和10 min(T 10)之前和之后获得静脉血样以确定%HbCO并量化Hb质量。在海平面和2320 m处对该协议进行了测试,以调查与海拔相关的测量误差。在海平面上,CO 0.5 -1和CO 0.5 -2之间的Hb质量平均差异(一致限的95%)为26 g(–26; 79 g),CO 1.5 -1和CO 1.5 -2之间的平均差异为是17克(–18; 52克)各自的典型误差(TE)分别对应于2.4%(CO 0.5)和1.5%(CO 1.5),而在2320 m处分别为6.5%和3.0%。使用CO 0.5时,缩短CO再呼吸会导致Hb质量的TE分别为4.4%(T 8对T 10)和14.1%(T 6对T 10),而CO 1.5时,TE分别为1.6%和5.8%。总之,可以以1.5-14.1%的测量误差为代价,减少用于CO再呼吸程序的CO剂量和再呼吸时间。

更新日期:2020-09-21
down
wechat
bug